Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney Disease

NCT01012414 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

10

Enrollment

OTHER

Sponsor class

Stopped Futility in enrollment as of May 31, 2011

Conditions

Coronary Artery Disease
Chronic Kidney Disease
Hypovitaminosis D
Secondary Hyperparathyroidism

Interventions

DRUG: paricalcitol
DRUG: placebo

Sponsor

Thomas Jefferson University

Collaborators

[object Object]